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Background. Renal masses are a biologically heterogeneous group of tumors ranging from 
benign masses to cancers that can be indolent or aggressive. Frequently, tumors are discovered 
incidentally and are asymptomatic at presentation. All imaging-enhanced solid renal masses 
are suspicious for renal cell carcinoma. In the case of a renal tumor, the vascular architecture 
can be modified. The therapeutic behavior is represented by the surgical techniques (total or 
partial nephrectomy). The most feared complications are severe bleeding that is difficult to 
control.  
Case report. We present a 59-year-old patient known with malignant renal tumor, admitted to 
Cluj-Napoca Oncological Institute. The patient undergoes surgical treatment, which consisted 
of anterior renal valve resection and tumor mass resection. Shortly after the intervention, the 
patient had macroscopic hematuria. A CT scan is performed with contrast substance that 
reveals vascular lesions suggestive of a pseudoaneurysm / renal arteriovenous fistula. The next 
step is digital angiography by subtraction (DSA) which indicates the presence of pseudo-
aneurysm in the renal parenchyma incriminated as a cause of hematuria. Considering the 
patient's age and the possibility of preserving the kidney, the therapeutic option applied is the 
endovascular treatment that involves the embolization of the aneurysm. By Zellinger approach 
is performed the catheterization of the right renal artery and the supraselective catheterization 
of the aneurysm, followed by embolization using a embolic liquid agent as mixture of Lipidiol 
and Glubran. The exclusion from the circulation of the aneurysm is obtained and the 
hemorrhagic (hematuric) source is eliminated. At the control injection the aneurysmal 
formation is complete ocluded, with very good imaging and clinical result. The control 
angiography after 6 months shows normal renal vascularization.  
Conclusions. The therapeutic option of performing a nephrectomy is very aggressive for the 
patient. Due to the interdisciplinary approach, interventional radiology techniques can offer 
minimally invasive therapeutic solutions, sometimes unique in rescuing patients.  
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Background. Symptoms of idiopathic overactive bladder (iOAB) affect ∼17 % worldwide of 
women, and its prevalence increases with patient age. Autonomic dysfunction in the genital 
area can be assessed using sympathetic skin response (SSR). SSR tests can be used for the 
detection of early iOAB and assessing those likely to be refractory to anticholinergic drugs. 
Treatments options for iOAB include lifestyle modifications, behavioural therapy, 
pharmacotherapy, neuromodulation, Botulinum toxin therapy and surgical interventions. The 
American Urological Association and the European Association of Urology recommend 
bladder wall injection with Botulinum neurotoxin A (BoNT-A) in women with idiopathic 
detrusor overactivity who have not responded to conservative treatment.  
Case report. Pacient I., female, age 31 years, diagnosed clinical with iOAB, confirmed on 
urodynamics, underwent the SSR investigation for assessment of autonomic nervous system. 
The patient had been refractory to different anticholinergic drugs and there was no response to 
conservative therapy for over 10 years. Before injection, patient was asked to complete a 4-day 
voiding diary, to record the quantification, the frequency of voids, the number of incontinence 
episodes and the number of episodes of nocturia. The treatment started with antibiotic 
prophylaxis (ciprofloxacin 1g i/v twice daily) for 1 day before the injection procedure and 
continued for 3 days after treatment. Saline cystoscopy was performed using a 19-F rigid 
cystoscope, under i/v anaesthesia. BoNT-A (100 UI) was mixed with 10 ml 0.9 % sodium 
chloride and administered 1 ml over 20 different sites, each 1 cm apart, supratrigonally, using 
18-gauge needle for rigid cystoscopies, inserted 3 mm into the bladder wall. After 2-3h of 
procedure was a successful demonstration of voiding. The woman didn’t develop any adverse 
effects like urinary tract infection, gross haematuria, injection site pain or urinary retention. 
Follow-up at 1, 3, 6, 9 and 12 months, with 4-day voiding diaries, clinical and SSR was carried 
out. Injections increased voided volume >90 ml, decreased urinary frequency, absence of 
nocturia and improved QoL. Clinical effects of BoNT-A were evident in 1 week and last up to 
12 months. The results of SSR before and after a week of injection estableshed the significantly 
pronounced changes in time taken for the ascending wave A1 (parasympathetic component) 
compering with time taken for the ascending wave A2 (sympathetic component). Before 
injection of BoNT-A mean score was S1A1=0,5sec., S2aA2=0,94 sec., after injection 
respectively was 0,34 sec. and 1,1 sec.  
Conclusions. Botulinum toxin type A might be an alternative to invasive surgery for patients 
in whom conservative measures for treatment of iOAB have failed. The SSR can serve as a 
complex diagnostic of iOAB and assessment the efficiency of treatment with BoNT-A.   
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Background. Ocular burns represent about 11-22% of ocular trauma. The most affected are 
young men, 20-40 y. o. These can happen anywhere, at home, work or after physical 
aggression. The most severe damage is due to acids and alkali. They can destroy limbal stem 
